An indolent B-cell lymphoma with t(2;8)(p12;q24) abnormality and absence of C-MYC amplification and TP53 deletion.: A new variant?

被引:2
|
作者
Potti, A
Panwalkar, A
Ingebretson, MC
Tharapel, SA
Goodell, M
Dayton, MV
Mehdi, SA
机构
[1] Univ N Dakota, Sch Med, Vet Affairs Med Ctr, Div Hematol Oncol, Fargo, ND 58102 USA
[2] Univ N Dakota, Sch Med, Dept Med, Fargo, ND USA
[3] Vet Affairs Med Ctr, Dept Pathol, Cytogenet Reference Lab, Memphis, TN USA
[4] Univ Minnesota, Dept Hematopathol, Minneapolis, MN USA
关键词
D O I
10.1016/S0165-4608(02)00931-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The translocation between chromosomes 2 and 8, t(2;8), is well known for its strong association with high-grade Burkitt lymphoma. However, the significance of this translocation in indolent lymphoproliferative disorders is not clear. We present the case of a 75-year-old white male with left upper quadrant abdominal pain, splenomegaly, and an elevated white cell count of 30.3 x 10(9) cells/L (84% large lymphoid cells with scanty cytoplasm and prominent central nucleoli). Immunophenotyping revealed a clonal B-cell population coexpressing CD5, CD19, and CD20 with weak CD23 and CD25 and very weak, restricted, surface lambda. The cytogenetic analysis showed all 20 cells with t(2;8)(p12;q24.3). In addition, four of the 20 cells also showed a second translocation: t(12;17)(p13;q21). Molecular analysis using c-myc and p53 probes showed normal results with no indication of amplification of C-MYC or deletion of TP53. The patient was managed as an indolent/low-grade lymphoproliferative disorder with excellent response to eight cycles of fludarabine. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:76 / 79
页数:4
相关论文
共 40 条
  • [31] In pediatric mature B-cell non Hodgkin lymphoma (NHL), complex karyotype or del(13q) are linked prognostic factors in Burkitt lymphoma (BL) while 8q24/c-myc rearrangement is associated with a strong adverse effect in diffuse large B-cell lymphoma (DLBCL).
    Poirel, HA
    Heerema, NA
    Swansbury, J
    Aupérin, A
    Launay, E
    Sanger, WG
    Talley, P
    Raphael, M
    Perkins, S
    McCarthy, K
    Sposto, R
    Weston, C
    Gerrard, M
    Cairo, MS
    Bernheim, A
    Patte, C
    BLOOD, 2005, 106 (11) : 541A - 541A
  • [32] Triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma associated with a novel complex karyotype including t(2;3)(q21;q27), t(8;14)(q24;q32) and t(14;18)(q32;q21)
    Nakayama, Shoko
    Yokote, Taiji
    Iwaki, Kazuki
    Takayama, Ayami
    Tsuji, Motomu
    Hanafusa, Toshiaki
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) : 569 - 569
  • [33] Development of a D FISH Probe Set for the t(822)(q24 1 q11 2) (c MYC/IgL) Seen in Burkitt Lymphoma and Other High Grade B cell Lymphomas
    Sakai, Y.
    Knudson, R. A.
    Wiktor, A. E.
    Keefe, J. G.
    Pearce, K. E.
    Meilinger, C. A.
    Bedroske, P. P.
    Sattler, C. A.
    Cousin, M. A.
    Ketterling, R. P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 874 - 874
  • [34] A double-hit High-grade B-cell lymphoma with three-way translocation t(3;8;14)(q27;q24;q32) involving BCL6, MYC, and IGH
    De Paoli, Elena
    Bandiera, Laura
    Ravano, Emanuele
    Cesana, Clara
    Grillo, Giovanni
    Mancini, Valentina
    De Canal, Gabriella
    Bonoldi, Emanuela
    Soriani, Silvia
    CLINICAL CASE REPORTS, 2018, 6 (12): : 2411 - 2415
  • [35] A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(p11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-myc protein
    Iida, S
    Hanamura, I
    Suzuki, T
    Kamiya, T
    Kato, M
    Hayami, Y
    Miura, K
    Harada, S
    Tsuboi, K
    Wakita, A
    Akano, Y
    Taniwaki, M
    Nitta, M
    Ueda, R
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 72 (01) : 85 - 91
  • [36] A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma
    Yamamoto, Katsuya
    Matsuoka, Hiroshi
    Yakushijin, Kimikazu
    Funakoshi, Yohei
    Okamura, Atsuo
    Hayashi, Yoshitake
    Minami, Hironobu
    CANCER GENETICS, 2011, 204 (09) : 501 - 506
  • [37] Case report: CD8 positive T-cell Prolymphocytic Leukemia presenting complex karyotype with a rare chromosomal abnormality der(2)t(1;2)(q21;q37) and additional signals of the genes MYC, IGH, and TP53
    Jamur, Valderez Ravaglio
    Lisboa, Mateus de Oliveira
    Azambuja, Ana Paula
    Brofman, Paulo Roberto Slud
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S393 - S397
  • [38] MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy (vol 9, e002029, 2021)
    Wang, J.
    Shang, Z.
    Wang, J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [39] ESTABLISHMENT OF A NEW EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-POSITIVE B-CELL LINE, BALL-2, WITH T(8-14) (Q24-Q32) CHROMOSOME ABNORMALITY FROM B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, L2
    KUBONISHI, I
    DAIBATA, M
    YANO, S
    ISOBE, M
    KUROSAWA, N
    NAGUMO, H
    OGITA, Z
    OHYASHIKI, JH
    TOYAMA, K
    MIYOSHI, I
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 37 (03) : 179 - 185
  • [40] Successful treatment of both double minute of C-MYC and BCL-2 rearrangement containing large B-cell lymphoma with subsequent unfortunate development of therapy-related acute myeloid leukemia with t(3;3)(q26.2;q21)
    Nguyen, John C.
    Kubik, Melanie J.
    Broome, H. Elizabeth
    Curtin, Peter T.
    Dell'Aquila, Marie L.
    Wang, Huan-You
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (11) : 883 - 891